Free Trial
NYSE:VTR

Ventas Q2 2025 Earnings Report

Ventas logo
$65.80 +0.43 (+0.66%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$65.60 -0.20 (-0.30%)
As of 07/18/2025 06:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ventas EPS Results

Actual EPS
N/A
Consensus EPS
$0.85
Beat/Miss
N/A
One Year Ago EPS
N/A

Ventas Revenue Results

Actual Revenue
N/A
Expected Revenue
$1.37 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Ventas Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Thursday, July 31, 2025
Conference Call Time
10:00AM ET

Conference Call Resources

Ventas Earnings Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Ventas Looks Bullish
See More Ventas Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ventas? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ventas and other key companies, straight to your email.

About Ventas

Ventas (NYSE:VTR) (NYSE: VTR) is a premier real estate investment trust (REIT) specializing in properties for the healthcare sector. The company’s core focus areas include seniors housing communities, medical office buildings, life science and innovation campuses, and skilled nursing facilities. Through long-term operating leases, sales-leasebacks and joint ventures, Ventas provides capital solutions to best-in-class operators and developers, enabling them to deliver quality care and services.

With a diversified portfolio spanning the United States, Canada and the United Kingdom, Ventas partners with leading healthcare and senior living providers to support growing demand for modern, amenity-rich environments. The company’s assets range from independent living and assisted living communities to state-of-the-art research hubs and outpatient medical campuses. Ventas’ geographically balanced footprint helps mitigate local market fluctuations while serving a broad demographic of seniors, patients and medical professionals.

Since its founding in 1998, Ventas has grown through disciplined acquisitions, strategic dispositions and value-creating joint ventures. The company has established a reputation for proactive portfolio management—optimizing asset performance, redeploying capital into high-growth subsectors and nurturing long-term operator relationships. Over the years, Ventas has refined its investment approach to emphasize sustainable building practices, innovative design and patient-centric environments that meet evolving regulatory standards and demographic trends.

Led by Chair and Chief Executive Officer Debra Cafaro, Ventas is headquartered in Chicago, Illinois. Under her leadership, the company has cultivated a strong corporate culture marked by governance rigor, financial discipline and a focus on environmental, social and governance (ESG) initiatives. Ventas continues to leverage its healthcare real estate expertise to support the changing needs of aging populations and the expansion of medical research and care delivery networks.

View Ventas Profile

More Earnings Resources from MarketBeat